Willow Biosciences Inc. (CANSF)
OTCMKTS
· Delayed Price · Currency is USD
0.0240
0.00 (0.00%)
Jun 5, 2025, 8:00 PM EDT
Willow Biosciences Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -4.15 | -6.19 | -13.03 | -14.81 | -6.14 | -33.95 | Upgrade
|
| Depreciation & Amortization | 1.04 | 1.38 | 1.82 | 2.6 | 3.08 | 3.07 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0.01 | 0.05 | 0.11 | 0.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.14 | - | -0.02 | 0.09 | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.02 | 0.45 | - | 6.12 | Upgrade
|
| Stock-Based Compensation | 0.1 | 0.3 | 0.42 | 1.46 | 1.7 | 0.95 | Upgrade
|
| Other Operating Activities | 0.23 | 0.16 | -0.02 | -3.72 | -16.75 | 11.04 | Upgrade
|
| Change in Accounts Receivable | -0.02 | - | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 0.35 | - | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.56 | 0.76 | -0.21 | 0.13 | -0.32 | -0.21 | Upgrade
|
| Operating Cash Flow | -2.01 | -3.72 | -10.98 | -13.86 | -18.23 | -12.78 | Upgrade
|
| Capital Expenditures | -0.02 | -0.02 | -0.61 | -0.68 | -1.67 | -0.95 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.14 | 0.01 | 0.12 | 0.12 | 0.05 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.01 | -0 | -0.1 | 0.07 | Upgrade
|
| Investment in Securities | - | - | 4 | -4.02 | - | - | Upgrade
|
| Other Investing Activities | -0.04 | -0.04 | 0.08 | 0.03 | -0.03 | -0.01 | Upgrade
|
| Investing Cash Flow | -0.06 | 0.08 | 3.47 | -4.55 | -1.67 | -0.84 | Upgrade
|
| Long-Term Debt Issued | - | - | 0.8 | - | - | - | Upgrade
|
| Total Debt Issued | - | - | 0.8 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.86 | -1.01 | -0.72 | -0.64 | -0.65 | Upgrade
|
| Total Debt Repaid | -0.93 | -0.86 | -1.01 | -0.72 | -0.64 | -0.65 | Upgrade
|
| Net Debt Issued (Repaid) | -0.93 | -0.86 | -0.21 | -0.72 | -0.64 | -0.65 | Upgrade
|
| Issuance of Common Stock | 0 | 0 | - | - | 37.57 | 11.5 | Upgrade
|
| Other Financing Activities | 1.66 | 1.64 | -0.04 | - | -2.81 | -0.96 | Upgrade
|
| Financing Cash Flow | 0.74 | 0.79 | -0.25 | -0.72 | 34.13 | 9.89 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | 0.05 | -0.09 | 0.03 | -0 | -0.02 | Upgrade
|
| Net Cash Flow | -1.46 | -2.81 | -7.86 | -19.11 | 14.22 | -3.75 | Upgrade
|
| Free Cash Flow | -2.03 | -3.74 | -11.59 | -14.54 | -19.9 | -13.73 | Upgrade
|
| Free Cash Flow Margin | -31.90% | -80.29% | -988.82% | -1771.26% | -14960.15% | -137320.00% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.09 | -0.12 | -0.17 | -0.17 | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0.01 | 0.05 | - | - | Upgrade
|
| Levered Free Cash Flow | -1.58 | -1.35 | -6.85 | -8.34 | -11.49 | -7.16 | Upgrade
|
| Unlevered Free Cash Flow | -1.39 | -1.18 | -6.76 | -8.32 | -11.47 | -7.14 | Upgrade
|
| Change in Net Working Capital | 0.41 | -0.64 | -0.03 | 0.25 | 0.11 | -0.14 | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.